Symyx Technologies Inc

Symyx Technologies — Merger or Acquisition (April 2010)

15 slides from Symyx Technologies's merger presentation, Apr 5, 2010

  1. Slide 1: Accelrys & Symyx Investor Presentation

    Accelrys & Symyx Investor Presentation

  2. Slide 2: Safe Harbor Information

    Company Confidential Safe Harbor Information 2 Non-historical statements in this presentation are forward- looking statements under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks, uncertaint

  3. Slide 3: Accelrys and Symyx to Merge

    Company Confidential Accelrys and Symyx to Merge 3 Accelrys and Symyx Agree to Merge • Companies have entered into definitive merger agreement • Transaction expected to complete by end of June 2010 subject to shareholder approval Merger Outcome • Creates the leading enterprise scientific informatics

  4. Slide 4: Combining Industry Leaders

    Company Confidential Combining Industry Leaders 4 Founded: 2001 Public: ACCL (NASDAQ) FY 2009 Revenue: $80.9M Leading positions in: § Data Collection and Analysis § Data Access, Integration & Transformation § Scientific Modeling and Simulation § Workflow Automation and Optimization Employees: 370 He

  5. Slide 5: Scientific R&D Challenges Balance Innovation, Automation, Collaboration

    Company Confidential Scientific R&D Challenges Balance Innovation, Automation, Collaboration Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards. Eric David, Tony Tramontin, and

  6. Slide 6: Combined Company Addresses Required Needs

    Company Confidential Combined Company Addresses Required Needs 6 Unequaled capabilities in scientific software and services Ø Deep domain expertise in chemistry, biology and materials science Ø Ability to improve scientific R&D processes and their outcomes Ø Unique, open, enterprise scale informatic

  7. Slide 7: Combined Company Solution

    Company Confidential Combined Company Solution Decision Support and Analytics Workflow Automation Deep analysis of complex scientific information Optimize processes and capture best practices Derivation of models, improved scientific insights and understanding Process optimization, deployment of bes

  8. Slide 8: Leading in Scientific R&D Workflows in Growing Markets

    Company Confidential Leading in Scientific R&D Workflows in Growing Markets Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System 8 Create, Execute and Reuse Scien

  9. Slide 9: Global Brand Customer Portfolio and Minimal Product Overlap

    Company Confidential With Global Brand Customer Portfolio and Minimal Product Overlap Customer Synergies Complementary Product Lines 9 Accelrys + Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5

  10. Slide 10: Vibrant & Growing Partner Ecosystem

    Company Confidential Vibrant & Growing Partner Ecosystem Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System 10 Additional applications and solutions developed b

  11. Slide 11: Terms of Deal

    Company Confidential Terms of Deal Merger Agreement Tax-free, all stock merger of equals Closing Expected to close end of June 2010 Exchange Ratio 0.7802 Ownership Each company’s stockholders will own approximately 50% of combined company Market Capitalization Combined market cap of ~ $335M (pre-ann

  12. Slide 12: Pro Forma Combined CY2009 Financial Metrics

    Company Confidential Metric (1) Accelrys Symyx Pro Forma Combined (2) CY2009 Revenue $82.2 $88.6 $170.8 CY2009 EBIT $6.0 $11.0 $17.0 CY2009 EBITDA (5) $7.8 $14.0 $21.8 Net Cash (3) $72.0 $81.8 $153.8 Market Capitalization (4) $179.8 $155.1 $334.9 Pro Forma Combined CY 2009 Financial Metrics 12 (1) S

  13. Slide 13: Accelrys & Symyx

    Accelrys & Symyx

  14. Slide 14: Forward Looking Statements

    Company Confidential Forward Looking Statements 14 Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to a variety of matters, including but not limited to: the timing

  15. Slide 15: Important Merger Information and Where to Find It

    Company Confidential Important Merger Information and Additional Information and Where to Find It 15 This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed merger, Accelr

Symyx Technologies — Merger or Acquisition (April 2010) on 6ix